Will histone deacetylase inhibitors require combination with other agents to fulfil their therapeutic potential?

Nolan, L, Johnson, P W M, Ganesan, A ORCID: https://orcid.org/0000-0003-4862-7999, Packham, G and Crabb, S J (2008) Will histone deacetylase inhibitors require combination with other agents to fulfil their therapeutic potential? British Journal of Cancer, 99 (5). pp. 689-694. ISSN 0007-0920

Full text not available from this repository. (Request a copy)

Abstract

Histone deacetylase inhibitors have progressed rapidly from the laboratory to clinical testing. This review highlights the promising data for their combination with a wide range of established and novel anticancer agents and discusses the mechanisms that underpin these interactions.

Item Type:	Article
Faculty \ School:	Faculty of Science > School of Pharmacy Faculty of Social Sciences > School of Education and Lifelong Learning
UEA Research Groups:	Faculty of Science > Research Groups > Chemical Biology and Medicinal Chemistry (former - to 2021)
Depositing User:	Users 2731 not found.
Date Deposited:	20 Oct 2011 11:44
Last Modified:	24 Oct 2022 01:01
URI:	https://ueaeprints.uea.ac.uk/id/eprint/35116
DOI:	10.1038/sj.bjc.6604557

Actions (login required)

View Item